Compounds > 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium
Page last updated: 2024-09-05

1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and Parakeratosis

1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium has been researched along with Parakeratosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AJ; Harrison, CA; Hau, Z; Johnson, TS; Layton, CM; MacNeil, S1

Other Studies

1 other study(ies) available for 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and Parakeratosis

ArticleYear
Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin.
    The British journal of dermatology, 2007, Volume: 156, Issue:2

    Topics: Cell Differentiation; Cell Proliferation; Enzyme Inhibitors; Humans; Imidazoles; Immunohistochemistry; Keratinocytes; Keratins; Mucin-1; Parakeratosis; Putrescine; Skin; Tissue Engineering; Transglutaminases

2007